Artículos relacionados
[Translated article] RF – Resistance to Permethrin in Scabies Treatment: Does It Really Exist?
septiembre 26, 2023
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 114. Núm. 5. (Mayo 2023)
Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences
diciembre 27, 2022
Área salud, Actas Dermo-Sifiliográficas, Elsevier España, Medicina, Vol. 113. Núm. 4. (Abril 2022)
Topical imiquimod has been used off-label as monotherapy or adjuvant treatment for lentigo maligna. Our aim is to describe treatment modalities, clinical outcomes, and management of recurrence in patients receiving imiquimod for lentigo maligna. Patients […]
Experience with erenumab: Data from real clinical practice
diciembre 27, 2022
Área salud, Elsevier España, Medicina, Neurology Perspectives, Vol. 2. Issue. 3. (July - September 2022)
Introduction The development of monoclonal antibodies against calcitonin gene-related peptide has represented a revolution in the treatment of migraine. Erenumab was the first of these drugs to be available in clinical practice in our setting. […]